€413,664
▼ Sales (16 ops.)
Insider track record
OtherAcross 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Cline Christopher R.. Director active across 1 company, notably Travere Therapeutics, Inc.. Aggregated, 25 reports have been logged. Breakdown: 0 buy · 16 sells. Total volume traded: €414k. History available since 1 September 2022. The latest transaction was disclosed on 15 April 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Cline Christopher R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
14,000 shares0Common StockSEC:0001943192-26-000003:0
65 shares@ US$28.850.0000% mcap0.4% of flowCommon StockSEC:0001943192-26-000003:1
9 shares@ US$41.070.0000% mcap0.1% of flowCommon StockSEC:0001943192-26-000003:2
7,239 shares@ US$41.92880.0055% mcap72.4% of flowCommon StockSEC:0001943192-26-000003:3
1,014 shares@ US$42.610.0008% mcap10.3% of flowCommon StockSEC:0001943192-26-000003:4
1,635 shares@ US$32.14Common StockSEC:0001943192-26-000002:0
28,130 shares0Common StockSEC:0001943192-26-000001:0
20,000 shares@ US$16.2343.1% of flowCommon StockSEC:0001943192-25-000005:0
454 shares@ US$18.201.9% of flowCommon StockSEC:0001415889-25-023786:0
470 shares@ US$17.311.9% of flowCommon StockSEC:0001415889-25-023209:0
4,920 sharesCommon StockSEC:0001415889-25-012061:0
48 shares@ US$13.14460.9% of flowCommon StockSEC:0001415889-25-010643:0
21,500 shares0Common StockSEC:0001415889-25-003062:0
865 shares@ US$18.940926.5% of flowCommon StockSEC:0001415889-25-001999:0
6,750 shares0Common StockSEC:0001415889-24-023091:0
514 shares@ US$9.50937.4% of flowCommon StockSEC:0001415889-24-022992:0
54 shares@ US$6.740.6% of flowCommon StockSEC:0001415889-24-010754:0
25,000 shares0Common StockSEC:0001415889-24-002280:0
853 shares@ US$9.068412.0% of flowCommon StockSEC:0001415889-24-001798:0
457 shares@ US$14.710210.6% of flowCommon StockSEC:0001209191-23-048258:0
455 shares@ US$16.5911.6% of flowCommon StockSEC:0001209191-23-029023:0
47 shares@ US$21.491.6% of flowCommon StockSEC:0001209191-23-024205:0
20,250 shares0Common StockSEC:0001209191-23-006422:0
852 shares@ US$21.904428.9% of flowCommon StockSEC:0001209191-23-005032:0
5,000 shares0Common StockSEC:0001209191-22-048347:0
About Cline Christopher R.
Cline Christopher R. is a declarant linked to Travere Therapeutics, Inc., where the stated role is CHIEF FINANCIAL OFFICER. Across the 15 filings recorded, the 15 sampled filings between 2022-09-01 and 2025-05-05 are all sales, with total sell volume of EUR 59392 and no purchases.